Potti retraction tally grows to six with a withdrawal in PLoS ONE, and will likely end up near a dozen

Anil Potti and his former Duke colleagues have retracted a sixth paper, this one in PLoS ONE. According to the retraction notice for “An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer,” the withdrawal was prompted by the retraction of a Nature Medicine paper that formed the basis of the … Continue reading Potti retraction tally grows to six with a withdrawal in PLoS ONE, and will likely end up near a dozen

Third retraction from dismissed Montreal cardiology researcher Zhiguo Wang appears

Ten days ago, we reported on the dismissal of Zhiguo Wang, a Montreal Heart Institute researcher who had already retracted two papers because of image manipulation. At the time, an official said the institute had requested three more retractions, but when we asked which three papers, we were told: As written in the press release, the MHI has … Continue reading Third retraction from dismissed Montreal cardiology researcher Zhiguo Wang appears

Anil Potti failed to disclose corporate ties in yet-to-be-retracted JAMA papers

Anil Potti, the former cancer researcher whose work has become the subject of intense scrutiny that has already led to the retraction of five papers, didn’t tell the Journal of the American Medical Association (JAMA) about two very relevant corporate relationships he had when he published papers there, Retraction Watch has learned. JAMA has published two papers by … Continue reading Anil Potti failed to disclose corporate ties in yet-to-be-retracted JAMA papers

Another retraction for Jatinder Ahluwalia, in Journal of Neurochemistry

The Journal of Neurochemistry will retract a paper by Jatinder Ahluwalia, the scientist who recently left his post at the University of East London following an investigation into his work. Ahluwalia was lead author of the 2003 paper, “Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release,” while earning his PhD at Imperial College … Continue reading Another retraction for Jatinder Ahluwalia, in Journal of Neurochemistry

Ties that don’t bind: Group retracts parathyroid hormone crystallography paper

The authors of a 2008 paper alleging to have described how a particular protein binds to the parathyroid hormone have retracted it. The paper, “Structure of the Parathyroid Hormone Receptor C Terminus Bound to the G-Protein Dimer Gβ12,” has been cited 12 times, according to Thomson Scientific’s Web of Knowledge. According to the notice:

Is it time for a Retraction Index?

We often hear — with data to back the statement — that top-tier journals, ranked by impact factor, retract more papers than lower-tier journals. For example, when Murat Cokol and colleagues compared journals’ retraction numbers in EMBO Reports in 2007, as Nature noted in its coverage of that study (h/t Richard van Noorden): Journals with high impact factors … Continue reading Is it time for a Retraction Index?

Two papers to be retracted after ORI finds misconduct by Boston University cancer researcher

The U.S. Department of Health and Human Services’ Office of Research Integrity (ORI) has found that a Boston University cancer researcher made up experiments reported in two papers funded by National Cancer Institute and National Institutes of Health grants. According to the ORI notice: Sheng Wang, PhD, Boston University School of Medicine Cancer Research Center: … Continue reading Two papers to be retracted after ORI finds misconduct by Boston University cancer researcher

Happy anniversary, Retraction Watch: What we’ve learned, and what’s in store for year two

Today marks the 1-year anniversary of the launch of Retraction Watch. We’d like to thank our readers, tipsters, and fans for your support and feedback — and our helpful critics who have spurred us to do better. Over the past 12 months we’ve written more than 250 posts about retractions ranging from the extraordinary — think … Continue reading Happy anniversary, Retraction Watch: What we’ve learned, and what’s in store for year two

Sebastiani group retracts genetics of aging study from Science

When a group of researchers last year claimed to have found a “genetic signature” to identify people likely to live to 100, they were questioned immediately. Now they’ve retracted the controversial paper —  but continue to stand behind their assertion. The paper had been the subject of an “Expression of Concern” in November. The retraction … Continue reading Sebastiani group retracts genetics of aging study from Science